Canary Health Technologies

Canary Health Technologies is a private health technology and diagnostics company developing handheld, point-of-care disease detection systems based on breath and fluid biomarker analysis. The company combines proprietary nanosensors, biomarker detection, and AI-enabled analytics to identify cancers, inflammatory conditions, infectious diseases, and treatment-response signals in real time. Its core platform appears to include breath-based detection under the AiroStotle Detect brand and rapid liquid-sample digital immunoassay testing under the Pelican platform. Canary also positions its cloud-connected analytics as a tool for surveillance, adherence monitoring, precision medicine, and population health insights. The company is not a therapeutic drug developer; it is best characterized as a diagnostics and medtech platform company operating across early detection and digital diagnostic workflows.